Introduction
Human immunodeficiency virus type I (HIV-1) is widely accepted as the cause of AIDS. It is also believed that HIV-1 itself is sufficient to cause immunodeficiency and to destroy parenchyma cells inducing widespread organ failure. Despite the unquestionable success in diagnosis and therapy of this disease, there are many unanswered questions. The substantial argument of this predication is the fact that it is still not possible to stop the worldwide pervasion of AIDS, especially in Africa and Asia. Without giving answers to all these questions a more successful treatment of patients cannot be expected. The fight against this disease is challenging and should be realized in a more complex manner, overcoming all the taboos and dogmas surrounding the disease. It is necessary to deliberate other potential factors, not only HIV, which may take part in this disease. Plasma HIV RNA is dramatically reduced in HIV/AIDS patients treated with highly active antiretroviral therapy (HAART), but residual viral replication is detected after suppression of plasma viraemia (Chun et al., 2000; Cusisni et al., 2004) . It has also been expressly proven that various forms of HIV reservoirs persist in practically all patients receiving HAART (Finzi et al., 1997; Siliciano et al., 2003) . The range of viral reservoirs in the human body is probably very much wider, as claimed in recent studies. Reservoirs were detected in macrophages and other cells of the blood system, in which even very effective HAART was not able to eliminate the virus. HIV persists in peripheral blood mononuclear cells despite sustained, undetectable plasma viraemia resulting from long-term antiretroviral therapy (Veazey et al., 1998; Brenchley et al., 2004) . The source of persistent HIV in these infected persons remains however unclear. Over the last period of time AIDS research has been focused on the gut and other mucosal tissue, and not blood, as the major site of HIV infection and CD4+ T cells loss (Veazey et al., 2005) . Mattapallil and Li both showed that the major focus of destruction of memory CD4+ T cells by simian immunodeficiency virus (SIV) is in mucosal cells, where most T cells expressing CD4 and CCR5 with a "memory" phenotype reside (Mattapallil et al., 2005; Li et al., 2005) . The loss of CD4 + T cells in the intestine coincided with productive infection of 2. Molecular biology analysis of bacteria and yeasts of HIV positive patients 2.1 Dot blot DNA hybridization. To verify this idea, bacterial DNA isolated from the gastrointestinal tract and blood DNA of 51 AIDS patients and 10 healthy subjects were tested for the presence of HIV-1 sequences by colony and dot blot hybridization (Zajac et al., , 2007 (Zajac et al., , 2011 . In dot blot hybridization, the lymphocyte/bacterial DNA of American and Slovak HIV/AIDS patients were in most cases positive (Figure 1 ). Of 27 patient samples, 23 lymphocyte DNA and 20 bacterial were positive, with respective 85% and 74%. Yet positivity of all the 41 patients tested was approximately the same. The selected patients 23, 33, 44, 78, 30, P1 and P15 are localized as follows: patient 23 in line 2 -position 1,2; patient 33 in line 1 -5,6; patient 44 in line 4 -3,4; patient 78 in line 6 -1,2; patient 30 in line 7 -1,2; patient P1 in line 7 -3,4 and patient P15 in line 7 -5,6. The intensity of the hybridization signal was in correlation with the origin of the probes used, the signal of human samples was more intensive with the applied human probes and vice versa for bacterial probes (data not shown). These findings suggest some differences in sequences between the two sources of material. The hybridization signals of samples from patients 96, 83, 62 (line 3, position 5, 6 ; line 4, position 1, 2; line 2, position 5, 6) were not intensive either in lymphocyte or bacterial DNA. These patients were classified as A1 stage of their CDC clinical category with CD4 + around 400/ l. The obtained results are in correlation with the common usage of 68; 69 primers in AIDS diagnostics. The hybridization signal was not detected in samples of control subjects, with the exception of samples from one subject (line 12, position 5,6). Bacteria and yeasts from the respiratory tract (nose, pharyngeal swabs) were isolated from 39 Cambodian and 28 Kenyan HIV-positive children. The majority of microbes were characterized as Staphylococcus aureus, Klebsiella pneumoniae and Candida albicans. In some cases, E. coli, Streptococcus pyogenes, Proteus mirabilis and Candida tropicalis were identified. Bacteria and yeasts of 16 Cambodian (41%) and 8 Kenyan (31%) children were found to be positive in colony and dot-blot DNA hybridization (17). Bacteria and yeasts from the respiratory tract of 41% of Cambodian ( Figure 2 ) and 31% of Kenyan HIV-positive children bear HIV-like sequences. The PCR specific for HIV sequences was carried out using HIV-1-specific primers. The analysis was performed by colony and dot-blot hybridization using HIV-1-specific primers, which represent gag, pol and env genes of the virus.
PCR and sequencing
Subsequently, bacterial DNA of positive isolates was amplified by the PCR using two sets of primers. The PCR products of 142 bp (primers 68;69, env gene of HIV-1 ) were detected in all The PCR products synthesized on the template of bacterial DNA analyzed and on the template of patient's DNA using primers from gag, pol and env genes were sequenced. By sequencing PCR products synthesized on the template of the patients' bacterial DNA using primers 68;69 env HIV-1 gene, 68for: AGCAGCAGGAAGCACTATGG, 69rev: CCAGACTGTGAGTTGCAACAG) homology greater than 90% with HIV-1 isolate HXB2 (HIVHXB2CG) was revealed. Sequences of intestinal bacteria of patients revealed at least 90% homology with three crucial HIV-1 genes (gag, pol, env) . Amplified fragments longer than 120 bp were directly sequenced on the ABI 373 DNA Sequencer. The sequences of 142 bp PCR products synthesized on the template of patients' lymphocyte (h) and bacterial (b) DNA, determined by primers 68; 69, were remarkably similar, with some differences occurring between isolates (Figure 4 ). These minor differences in the isolates strongly suggest that the DNA has a common recent ancestry in HIV-1. Important is the finding of rather marked differences between bacterial sequences and sequences of pBH10 in all fragments tested. On the basis of these results, the possibility of contamination of our samples by pBH10 plasmid DNA is practically excluded.
Protein analysis of patient's bacteria and yeasts
The expression of HIV-1 antigens in bacteria and yeasts of HIV positive patients was detected by using specific monoclonal antibodies against HIV-1 antigens p17, p24, p55, gp41 and gp120 (Abcam, UK). 55 kDa protein was detected using Detection was performed using monoclonal antibodies against HIV-1 p24. Line 1: p24 diluted 1:500; line 2: control bacteria Muta 104-0; lines 3-9 tested samples. 55 kDa protein was also detected in bacteria and yeasts from bacteria and yeasts of the respiratory tract (nose, pharyngeal swabs) of Cambodian (Km) and Kenyan (Ke) HIV positive children: 14Km, 17'Ke, 21Ke, 32'Km, 3'Km, 31Km, 14'Ke, using by MAbs against HIV1 p17, p55 (Figure 7) . . lines 1-6 tested samples. Line 7: serum of AIDS patient diluted 1:100; line 9: negative control bacteria Muta 104-0. In samples of Slovak and American HIV positive patients using MAbs against HIV p17, p55 proteins of about 30 kDa was found.
In addition, the protein of molecular weight 55 kDa was detected in Cambodian and Kenyan samples by MAbs anti HIV-1 p17 and p55. Its molecular weight is comparable to gag-encoded Pr55Gag precursor. By MAbs against HIV p24, protein of 55 kDa was found in Cambodian and Kenyan samples. Surprisingly, no proteins were found in bacterial extract of 10 American and 24 Slovak AIDS patients by this MAbs. Protein detected by Mabs against gp41 was identified in 30-35% of samples from all cohorts of patients. The protein of about 85 kDa was detected only in Candida species protein extracts of Cambodian and Kenyan HIV positive children by the MAbs against gp120. In Slovak and American samples, protein reacting with MAbs anti gp120 was not found. These results suggest that there are specific differences between bacterial proteins of Slovak and American HIV positive patients on one side and Cambodian and Kenyan on the other. These differences suggest a diverse bacterial evolution in various geographical areas. 
Tests for internalization capacity of patient's bacteria
The obtained results raise the question, what is the role of intestinal bacteria bearing HIV sequences in the AIDS process (Simon & Gorbach, 1984) . Analogous to the finding of Swidsinski (Swidsinski et al., 1998 (Swidsinski et al., , 2002 and our previous works ) that bacteria isolated from biopsies of polyps, adenomas, and carcinomas are able to internalize epithelial cells, we tested bacteria purified from the intestinal tract of Slovak and American HIV/AIDS patients for their capacity to be internalized by cells of HL-60 cell line and normal human lymphocytes. In the present study, the specific characteristic was found to be their vigorous ability to be internalized by HL-60 cells and human lymphocytes, as confirmed by a gentamicin protection assay. In comparison with intramucosal bacteria isolated from patients with colorectal cancer, their capacity to be internalized by normal human lymphocytes was 5-10 times higher and in most cases the cells were lysed. Bacteria 725/5 were classified as Enterobacter cloacae and all other clones tested were characterized as Escherichia coli. Internalization frequently resulted in partial (bacteria of patients M1, M22) or complete lysis (patients K1, M12) of HL-60 cells. Partial (patients P3, M22) and complete lysis (patients P1, K1, M1, M12) was detected also after infection of normal human lymphocytes. What is the fate of bacteria after internalization? As we demonstrate, about 50-60% of the bacteria of tested AIDS patients are competent to lyse HL-60 and lymphocytes of host cells. The remaining part of intracellular bacteria survived in the host cells for a further 7-10 days, as shown by GPA. After this time the GPA test was negative. It can be assumed that in nature some pathogenic bacteria which penetrated into the blood system may infect or lyse lymphatic cells. To analyze the role of bacteria in immunodeficiency, reduction of their amount in the intestinal tract of 20 AIDS patients was performed by oral administration of probiotic bacteria Escherichia coli strain Nissle 1917. After three months of probiotics treatment the viral load decreased or remained on the detection limit (<400 c/ml) in 55.5% of the patients tested. According to these findings, it is assumed that not only one biological component plays the most important role in the AIDS process, but that there are two -HIV and the bacterial host. These bacteria bearing rich extrachromosomal genetic information are able to penetrate from the GIT into the human body and attack strongly the human immune system.
Patient

Etiology and possible evolution of disease
The fundamental, still unanswered question is the origin of HIV (Gallo et al., 1985; Baltimore, 1985; Duesberg, 1987; Temin, 1988 Temin, , 1989 Varmus, 1989; Sharp et al., 2001; Zhu et al., 1998; Apetrei & Marx, 2005) . Is HIV a unique relative of other retroviruses? When looking at retroviruses, the rule applies that practically every species in the animal kingdom has its own retrovirus -mouse, rat, chicken, goat, sheep, cow, horse, monkey, chimpanzee, etc. Some of them are very contiguous, due to their phylogenetic relationship -mouse and rat, monkey and chimpanzee. Similarly, retroviruses of monkeys, chimpanzee and humans are evolutionarily collateral. Yet there is no substantial evidence about transmission of retroviruses between different species in nature. On the basis of these facts and our achieved results, it is possible to conclude -all retroviruses have been an integral part of a particular host organism since the beginning of their existence as species and they are passed on from generation to generation. The hosts -including humans -inherited them from their ancestors. In accordance with this idea, it is assumed that transfer of the HIV from apes to humans in Africa, as a consequence of their accidental contacts, is not the cause of AIDS pandemics.
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But there is a very serious objection -if HIV were in our bacteria from our beginning, why did they emerge only about 25-35 years ago? Were they hidden without any implication all the time, for many thousands of years, in our bodies? To answer this question, we should go back into the ancient history of humankind. In the past, major epidemics frequently occurred when there were new patterns of communication and transportation between separately populated areas and/or new patterns of settlement. The first recorded great plague occurred in Athens during the Peloponnesian war in 430 BC. In the middle of the sixth century AD (542), there was a great outbreak of bubonic plague (Justinianus) in the Mediterranean countries, where 40 to 50% of the population died. The biggest cataclysm of bubonic plague epidemic started in 1346 in Europe and the population was finally decimated by 50 to 60%. Plague subsequently spread to Asia and at least 60 million people died just only in China alone. This plague continued up to the seventeenth and partially to the eighteenth century. In the sixteenth century, after Europeans reached America, new devastating epidemics started among the native peoples resulting in a 90% population loss among American Indians within 120 years. Who were in particular the victims of these plagues? Mostly people who were malnourished, sick, with a debilitated immune system. As discussed above, bacteria carrying the rich extra-chromosomal genetic information, as plasmids, phages, transposomes, viruses and virus-like particles (HIV included), are mostly pathogenic for the host organism and continually attack the immune system after penetration. This attack depends on the amount of the microbes which penetrate into the blood. Thus the immune system of people with low amounts of these bacteria was stronger and their carriers had a chance to overwhelm any plague. One of the most important results of the set of plagues that occurred in the history of humankind, mainly in Europe, North Africa, North America and partially in Asia, was natural selection, resulting in sanitation of the human population. Hand in hand in this tremendous evolution process was the selection of people with a low level of bacteria carrying pathogenic, mainly extra-chromosomal genetic information, able to penetrate into the human body and attack the immune system. The outcome of this complex evolutional proceeding, which finished towards the end of the nineteenth century, was a great reduction of pathogenic bacteria in the human population and eventually the establishment of a balance between non-pathogenic and pathogenic ("good" and "bad") microbes in the microflora of surviving individuals. The effect of this process was limitation of bacteria bearing HIV sequences and the selection of people carrying CCR-5 receptor deficiency on white blood cells. A consequence of many plagues in the history of mankind was the establishment of a balance between prokaryotic and eukaryotic kingdoms in our body, which led to a positive selection of people with a low amount of viral and retroviral genetic information in their intestinal bacteria. This tremendous process, whose victims were many millions of humans, was very intensive particularly in Europe. The stability, acquired over many centuries, between eukaryotic and prokaryotic kingdoms was interrupted in the middle of the twentieth century due to the use of antibiotics, narcotic drugs and changes in life style (homo and anal sex). It is generally accepted that due to ATB practically all primary bacterial pathogens were liquidated throughout two-three decades. The success of antibiotics in elimination of many diseases induced by microbes was such expressive that in the mid-1950s US Surgeon General Steward effusively proclaimed that the era of bacterial diseases finished. This trend of ATB glorification was spread very quickly from USA to Europe and microbiology got to the scientific periphery. In 1969, only a few people heard the voice of the English scientist J. A. Reaburn who said that in the future years it would be shown that antibiotics could bring us unforeseen vicious tricks. In this way resistant, potentially pathogenic microbes, bearing rich extra-chromosomal genetic information as plasmids, phages, transposomes, virus-like particles (VLP) or viruses (including HIV), went from minority to majority and attacked the human immune system. Microbes employed their ability to change their shape -cell wall deficient (CWD) to survive in these hard conditions or were internalized into host cells (Swidsinski et al., 1998 (Swidsinski et al., , 2002 Martin et al., 2004; Beachey, 1981; Benjamin et al., Cohen & Laux, 1995) . Some of these microbes are able to overcome insurmountable barriers existing between microbial DNA and DNA of more highly organized beings. The result of this process are health troubles and one of them, induced by HIV bacteria with strong affinity to T lymphocytes, is immunodeficiency. This proceeding started between Afro-American drug users because they had not been going through plague selection and sanitation, as had other American inhabitants. Disease spread mainly in big American cities as Los Angeles, San Fransisco, New York, Chicago, and others. Microbes which might be harmless in a healthy body became deadly in conjunction with drugs. This hypothesis was put forward in an editorial of the New England Journal of Medicine by David Durack: Some new factors may have distorted the host-parasite relation. So-called "recreational" drugs are one possibility. They were widely used in the large cities where the most of these cases have occurred, and the only patients in the series reported with this issue who were not homosexual were drug users. Perhaps one of these recreational drugs is an immunosuppressive agent (Durack and Phil, 1981) . The leading candidates were nitrites, which were commonly inhaled in the years 1960 to 1977 to intensify orgasm. Butyl nitrite very probably plays an important role in induction of Kaposi's sarcoma in AIDS (Mirwish & Hawerkos, 1987) . Mice exposed to isobutyl nitrite showed dose-related immune system damage and became highly susceptible to disease and death caused by mycobacterial infection (Neefe et al., 1983) . The "classical" drugs have a similar but more intensive effect on the immune system and micro-flora of drug users. The elimination of "good" intestinal bacteria by continually used drugs opened the space for amplification of microbes, which had existed before in the minority. The result of this process is that the immune system is not able to react to the massive attack and many diseases are induced, as: pneumonia, tuberculosis, toxoplasmosis, Cryptococcus, hepatitis B, herpes simplex, cytomegalovirus, bacterial, yeast and fungal infections, lymph gland infections and immunodeficiency. Amplified pathogenic microbes are equipped with antibiotic resistance and some of them are bearing viral and retroviral genetic information. Many of these infections are chronic or recurring, often unrecognized at first, and difficult to treat. Consequent antibiotic treatment forwards the spiral process of natural micro-flora destruction. And finally, ingestion of antiretroviral drugs as AZT completed this distortion. The result of such continual, step by step attack of intestinal microbes is their unification, reduction of their heterogeneity and loss of their basic function for the host. In the intestinal tract of two American AIDS patients in the final phase we found only one type of bacteria bearing HIV-1 sequences -multi-resistant Escherichia coli with plasmids of about 50 kbp.
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Conclusion
Hypothetically, bacteria are probably hosts not only for HIV but also for other retroviruses. The presence of HIV sequences in commensurate bacteria of the patients may be explained as follows: 1) intestinal bacteria were infected by HIV or virus-like particles (VLP) previously produced by human cells, in particular by macrophages and lymphocytes; 2) intestinal bacteria of AIDS patients are a natural host of HIV sequences in the form of a virus or VLP. Effective vaccines for human immunodeficiency virus type 1 (HIV-1) will have to stimulate protective immunity in the intestinal mucosa, where HIV-1 infection causes severe CD4 + Tcell depletion (Bealshe et al., 1994; Bartlett et al., 2003) . While replication-competent recombinant adenovirus (rAd) vectors can stimulate adenovirus-specific mucosal immunity after replication, oral delivery of replication-defective rAd vectors encoding specific immunogens has proven challenging (Wang et al., 2009 ). Recent studies suggest that induction of primary immune responses by recombinant bacterial vectors leads to gut immunization and subsequent systemic boosting elicits potent antigen-specific gut mucosal responses. Genetically modified bacteria have been experimentally used as recombinant probiotics also in gastrointestinal disorders, but clinical usage is currently not the case. Nevertheless, in the future a greater use of this kind of approach is expected. The expression of HIV-1 antigens in specific probiotic strains may be suitable for clinical use as a potential vaccine.
